| Trial ID: | L6058 |
| Source ID: | NCT01889095
|
| Associated Drug: |
Biasp 30
|
| Title: |
Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Type 2
|
| Interventions: |
DRUG: BIAsp 30|DRUG: NPH/Reg
|
| Outcome Measures: |
Primary: Number Of Hypoglycemic events, 3 month |
|
| Sponsor/Collaborators: |
Sponsor: Tehran University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
160
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2011-07
|
| Completion Date: |
2012-07
|
| Results First Posted: |
|
| Last Update Posted: |
2013-06-28
|
| Locations: |
Tehran University of Medical Sciences, Tehran, 13145-784, Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01889095
|
